Dublin, March 11, 2025 (GLOBE NEWSWIRE) -- The "Molecular Infectious Disease Testing Market by Product & Service (Kits, Instruments), Type (Singleplex, Multiplex), Test Type (Lab, PoC), Disease (STD, ...

The diagnostics advisory committee reviewed the evidence available on the clinical and cost effectiveness of using multiplex allergen testing, in combination with standard clinical assessment, to help ...

The MosaiQ solution is a next-generation IVD solution for autoimmune diseases, allergies and beyond. The multiplexed, fully automated planar microarray platform enables syndromic testing for complex ...

The MosaiQ instrument is a next-generation, continuous random-access immunoassay platform offering labs automation, simple workflows, fast, multiplexed results and actionable insights for ...

Tick-borne diseases present a growing challenge in clinical practice, not only due to their rising incidence but also because of the complex nature of co-infections. Patients bitten by ticks are often ...

The global multiplex molecular diagnostics market is on a steady growth trajectory, with an anticipated CAGR of 5.4% during the forecast period. Valued at USD 23.2 billion in 2022, the market is ...

SEOUL, South Korea, Aug. 5, 2024 /PRNewswire/ -- Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, showcased its key products and ...

OnsiteGene introduces myNATTM, a sealed-cartridge PCR system delivering flexible, sample-to-answer molecular diagnostics with precision. LOS ALTOS, CA, UNITED STATES, September 11, 2025 /EINPresswire ...